Prognostic Factors and Predictors of Disease Flare in Patients With Rheumatoid Arthritis
Recruiting · NCT07381296 · Observational (researchers observe without assigning treatment) · Lead sponsor: Sohag University
View the official record on ClinicalTrials.gov →Interventions studied
What this trial is about
The goal of this observational study is to help find better ways to predict when a flare of your disease (rheumatoid arthritis) might happen. By looking at your registered data, symptoms, disease characteristics, and specific markers in your blood, the investigators hope to help doctors make better decisions about your treatment in the future. The main question it aims to answer is: Can specific patient data, disease characteristics, drug history, or markers in a patient's blood be used to predict when a rheumatoid arthritis flare is about to happen? Participants already diagnosed with rheumatoid arthritis and who have their disease controlled will be followed up every 3 months for any signs or symptoms of a flare.
Who can take part
Inclusion criteria
- Age: patients \>18 years old.
- Patients with rheumatoid arthritis diagnosed according to the 2010 American College of Rheumatology (ACR)/European Alliance of Associations for Rheumatology Classification Criteria for RA.
- Clinical remission or low disease activity according to the disease activity score in 28 joints (DAS28).
Exclusion criteria
- Age \< 18 years.
- Any autoimmune disease other than Rheumatoid arthritis. Severe infection, pregnancy, and malignancy.
Where it is running
1 location listed.
- Rheumatology and Rehabilitation Department, Faculty of Medicine, Sohag University - Sohag, Sohag Governorate, Egypt